Integrated BioPharma (INBP) Stock Price, News & Analysis

Company Overview

Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products. This segment also sells private label vitamin and nutritional supplement products through the Internet; provides warehousing and fulfilment services; and distributes fine natural botanicals, including multi minerals, as well as raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.

Key Stats

• Today's Range: $0.33 to $0.35
• 50-Day Range: $0.26 to $0.35
• 52-Week Range: $0.16 to $0.42
• Volume: 15,001 shs
• Average Volume: 23,642 shs
• Market Capitalization: $10.08 million
• P/E Ratio: 8.14
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

INBP Stock Analysis - Frequently Asked Questions

How have INBP shares performed this year?

Integrated BioPharma's stock was trading at $0.3297 on January 1st, 2025. Since then, INBP stock has decreased by 1.3% and is now trading at $0.3255.
View the best growth stocks for 2025 here.

How were Integrated BioPharma's earnings last quarter?

Integrated BioPharma Inc. (OTCMKTS:INBP) issued its earnings results on Wednesday, May, 14th. The company reported $0.02 earnings per share (EPS) for the quarter. The firm earned $13.95 million during the quarter. Integrated BioPharma had a trailing twelve-month return on equity of 6.36% and a net margin of 2.37%.

How do I buy shares of Integrated BioPharma?

Shares of INBP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Integrated BioPharma own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Integrated BioPharma investors own include GSK (GSK), Invitae (NVTA), Exxon Mobil (XOM), Autodesk (ADSK), Adaptive Biotechnologies (ADPT), Analog Devices (ADI) and Adaptimmune Therapeutics (ADAP).

Company Calendar

• Last Earnings: 5/14/2025
• Today: 6/27/2025
• Fiscal Year End: 6/30/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED - DRUGS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:INBP
• CIK: 1016504
• Web: www.integratedbiopharma.com
• Phone: (973) 926-0816
• Fax: 973-926-1735
• Employees: 150
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): $0.04
• Trailing P/E Ratio: 8.75
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $110 thousand
• Net Margins: 2.37%
• Pretax Margin: 3.55%
• Return on Equity: 6.36%
• Return on Assets: 4.84%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 3.72
• Quick Ratio: 1.70

Sales & Book Value

• Annual Sales: $50.32 million
• Price / Sales: 0.22
• Cash Flow: $0.05 per share
• Price / Cash Flow: 7.77
• Book Value: $0.64 per share
• Price / Book: 0.55

Miscellaneous

• Outstanding Shares: 30,980,000
• Free Float: 10,160,000
• Market Cap: $10.84 million
• Optionable: Not Optionable
• Beta: 0.75